Bessemer Group’s Ventyx Biosciences VTYX Stock Holding History

Bessemer Group’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-520	Closed	-$1K	–	2713
2024 Q3	$1K	Buy	+520	New	+$1.2K	﹤0.01%	2573

Other funds holding VTYX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bessemer Group's VTYX Position: Q4 2024 in Review

Bessemer Group sold out of Ventyx Biosciences (VTYX) in Q4 2024, closing a stake of 520 shares — an estimated $1K sold.

Bessemer Group first reported a position in VTYX in Q3 2024 and held it in 1 quarter. The position peaked at $1K in Q3 2024. 124 funds tracked by Wall St. Rank hold VTYX as of Q4 2024.

Bessemer Group reported no remaining Ventyx Biosciences position as of Q4 2024 after selling out during the quarter.
Bessemer Group sold 520 Ventyx Biosciences shares in Q4 2024, an estimated $1K.
Bessemer Group first reported a position in Ventyx Biosciences in Q3 2024 and held it in 1 quarter.
Bessemer Group's Ventyx Biosciences position peaked at $1K in Q3 2024.
124 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2024.

Based on Bessemer Group's 13F filing for Q4 2024, filed 13 Feb 2025.